Covered recipient · General Payments record
ALEXIS R DUKE
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,612.03
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.78 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $215.01 | 24 |
| GENZYME CORPORATION | $31.83 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.19 | 1 |
| Lilly USA, LLC | $22.00 | 1 |
| Dermavant Sciences, Inc. | $21.73 | 1 |
| Incyte Corporation | $20.47 | 1 |
| Amgen Inc. | $20.03 | 1 |
| Arcutis Biotherapeutics, Inc. | $18.89 | 1 |
| UCB, Inc. | $17.82 | 1 |
| Almirall LLC | $14.17 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.10 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665056 | CMS |
| ABBVIE INC. | $10.83 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665058 | CMS |
| ABBVIE INC. | $14.65 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665060 | CMS |
| ABBVIE INC. | $5.14 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665062 | CMS |
| ABBVIE INC. | $20.37 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665064 | CMS |
| ABBVIE INC. | $7.53 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665066 | CMS |
| ABBVIE INC. | $4.55 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665068 | CMS |
| ABBVIE INC. | $7.52 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665070 | CMS |
| ABBVIE INC. | $10.58 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665072 | CMS |
| ABBVIE INC. | $14.06 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665074 | CMS |
| ABBVIE INC. | $5.93 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665076 | CMS |
| ABBVIE INC. | $7.80 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665078 | CMS |
| ABBVIE INC. | $5.68 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665080 | CMS |
| ABBVIE INC. | $4.21 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665082 | CMS |
| ABBVIE INC. | $6.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665084 | CMS |
| ABBVIE INC. | $20.08 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665086 | CMS |
| ABBVIE INC. | $5.94 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665088 | CMS |
| ABBVIE INC. | $5.39 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665090 | CMS |
| ABBVIE INC. | $15.29 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665092 | CMS |
| ABBVIE INC. | $7.12 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665094 | CMS |
| ABBVIE INC. | $3.86 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665096 | CMS |
| ABBVIE INC. | $10.83 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665098 | CMS |
| ABBVIE INC. | $4.66 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665100 | CMS |
| ABBVIE INC. | $6.93 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103665102 | CMS |
| Almirall LLC | $14.17 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120643185 | CMS |
| Amgen Inc. | $20.03 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117242678 | CMS |
| Arcutis Biotherapeutics, Inc. | $18.89 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121033538 | CMS |
| Dermavant Sciences, Inc. | $21.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127863222 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101263489 | CMS |
| GENZYME CORPORATION | $17.48 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799542 | CMS |
| GENZYME CORPORATION | $14.35 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139799556 | CMS |
| Incyte Corporation | $20.47 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141196125 | CMS |
| Lilly USA, LLC | $22.00 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136021448 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.19 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114040697 | CMS |
| UCB, Inc. | $17.82 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143028638 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.